Inventor
GAO YING-DUO
US28 patents
⚠️ This page may combine multiple inventors who share the name “GAO YING-DUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
9 patentsUS10123995B2Nov 13, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations72
US10011585B2Jul 3, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations72
US9868727B2Jan 16, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME3 citations72
US10093683B2Oct 9, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME4 citations71
US10081617B2Sep 25, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations70
US9481682B2Nov 1, 2016
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
MERCK SHARP & DOHME2 citations51
US7956061B2Jun 7, 2011
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
MERCK SHARP & DOHME1 citations51
US10214512B2Feb 26, 2019
Factor XIA inhibitors
MERCK SHARP & DOHME0 citations41
US9975874B2May 22, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME0 citations41
MERCK & CO INC
6 patentsUS6313298B1Nov 6, 2001
Spiro-indolines as Y5 receptor antagonists
MERCK & CO INC79 citations96
US6191160B1Feb 20, 2001
Spiro-indolines as Y5 receptor antagonists
MERCK & CO INC79 citations96
US6638942B1Oct 28, 2003
Spiro-indolines as Y5 receptor antagonists
MERCK & CO INC10 citations73
US6495559B2Dec 17, 2002
NPY Y5 receptor antagonists
MERCK & CO INC5 citations73
US7482336B2Jan 27, 2009
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
MERCK & CO INC3 citations62
US6864383B2Mar 8, 2005
Ophthalmic compositions for treating ocular hypertension
MERCK & CO INC0 citations51
MERCK SHARP & DOHME LLC
4 patentsUS12497403B2Dec 16, 2025
Factor XIa inhibitors
MERCK SHARP & DOHME LLC0 citations62
US12492187B2Dec 9, 2025
Factor XI activation inhibitors
MERCK SHARP & DOHME LLC0 citations49
US12428397B2Sep 30, 2025
Factor XI activation inhibitors
MERCK SHARP & DOHME LLC0 citations48
US12459927B2Nov 4, 2025
Plasma kallikrein inhibitors
MERCK SHARP & DOHME LLC0 citations44
CHILDRENS MEDICAL CENTER
3 patentsUS6028103AFeb 22, 2000
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
CHILDRENS MEDICAL CENTER36 citations90
US6800658B2Oct 5, 2004
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
CHILDRENS MEDICAL CENTER3 citations60
US7531573B2May 12, 2009
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
CHILDRENS MEDICAL CENTER0 citations38
NUCHEM PHARMACEUTICALS INC
2 patentsUS6534497B1Mar 18, 2003
Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
NUCHEM PHARMACEUTICALS INC3 citations56
US6992079B2Jan 31, 2006
Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
NUCHEM PHARMACEUTICALS INC0 citations35